Related references
Note: Only part of the references are listed.Comparative effect of canrenone or hydrochlorothiazide addition to valsartan/amlodipine combination on urinary albumin excretion in well-controlled type 2 diabetic hypertensive patients with microalbuminuria
Roberto Fogari et al.
EXPERT OPINION ON PHARMACOTHERAPY (2014)
Effects of canrenone in patients with metabolic syndrome
Giuseppe Derosa et al.
EXPERT OPINION ON PHARMACOTHERAPY (2013)
Human Red Blood Cells Alterations in Primary Aldosteronism
Luciana Bordin et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2013)
Polycystic ovary syndrome: Implications of measurement of plasma aldosterone, renin activity and progesterone
Decio Armanini et al.
STEROIDS (2012)
Effect of canrenone on left ventricular mechanics in patients with mild systolic heart failure and metabolic syndrome: The AREA-in-CHF study
G. de Simone et al.
NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES (2011)
Effect of canrenone and amiloride on the prooxidative effect induced by aldosterone in human mononuclear leukocytes in vitro
C. Fiore et al.
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2009)
The effect of spironolactone use on heart failure mortality: A population-based study
Maral Ouzounian et al.
JOURNAL OF CARDIAC FAILURE (2007)
Treatment of polycystic ovary syndrome with spironolactone plus licorice
Decio Armanini et al.
EUROPEAN JOURNAL OF OBSTETRICS GYNECOLOGY AND REPRODUCTIVE BIOLOGY (2007)
Differing effects of mineralocorticoid receptor-dependent and -independent potassium-sparing diuretics on fibrinolytic balance
J Ma et al.
HYPERTENSION (2005)
Effect of aldosterone and glycyrrhetinic acid on the protein expression of PAI-1 and p22phox in human mononuclear leukocytes
LA Calò et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
Effect of aldosterone blockade in patients with systolic left ventricular dysfunction: implications of the RALES and EPHESUS studies
B Pitt
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2004)
Aldosterone escape during blockade of the renin-angiotensin-aldosterone system in diabetic nephropathy is associated with enhanced decline in glomerular filtration rate
KJ Schjoedt et al.
DIABETOLOGIA (2004)
The spironolactone renaissance
SA Doggrell et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2001)
Share Paper
